Skip to main content

Martin Delaney Collaboratories for HIV Cure Research

Agency: National Institutes of Health

Assistance Listings
  • 93.855 -- Allergy and Infectious Diseases Research

Forecasted opportunityLast Updated: May 13, 2026

Important dates

  • Forecasted post date: April 21, 2026
  • Forecasted application due date: August 19, 2026
  • Forecasted award date: March 1, 2027
  • Forecasted project start date: March 1, 2027
  • Fiscal Year: 2027

Award details

  • Expected project funding: $20,000,000
  • Expected awards: 6

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:FOR-AI-27-001
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: June 10, 2025
  • Archive date: Not specified
  • Version: 1

View version history on Grants.gov

Summary

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the Martin Delaney Collaboratories (MDCs) for HIV Cure Research. The goal of the MDC program is to develop strategies to control viral replication without the need for lifelong antiretroviral therapy, with an ultimate goal of completely eradicating HIV reservoirs from the individual. The program will also address the unique needs of children living with HIV. The MDC program will accelerate HIV cure research by fostering strategic collaborations among academic institutions, scientists in government, the private sector, and community stakeholders. The program provides economies of scale by leveraging shared reagents, research resources, and specialized technologies in support of basic, translational, and clinical research. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

Eligibility

Education

  • Public and state institutions of higher education
  • Independent school districts
  • Private institutions of higher education

Government

  • County governments
  • Public and Indian housing authorities
  • Federally recognized Native American tribal governments
  • State governments

Business

  • For-profit organizations other than small businesses
  • Small businesses

Nonprofit

  • Nonprofits non-higher education with 501(c)(3)
  • Other Native American tribal organizations

Additional information on eligibility

Not specified

Documents

No documents are currently available.

Agency contact information

Email: diane.lawrence2@nih.gov

diane.lawrence2@nih.gov

Diane Lawrence, Ph.D. National Institute of Allergy and Infectious Diseases (NIAID) 240-627-3202

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov